Pulmonary infection caused by Strongyloides stercoralis in an immunocompromised patient. Case report
DOI:
https://doi.org/10.37135/ee.04.15.09Keywords:
Strongyloides stercoralis, Ivermectin, Immunocompromised HostAbstract
Strongyloides stercoralis is an intestinal nematode capable of completing its life cycle within the human host. The clinical case of a 57-year-old woman who has lived in the Amazon region for 10 years is presented. She has a personal pathological history of arterial hypertension, osteoporosis, and type 2 diabetes mellitus, which classifies her as immunocompromised. She attends emergency services with acute symptoms characteristic of urinary tract infection, receives treatment in the intensive care unit for septic shock of urinary versus pulmonary origin. The clinical laboratory test using a sample taken through bronchial aspiration shows the existence of active larvae of Strongyloides stercoralis. The patient's health conditions improved after a month of evolution, responding satisfactorily to antibiotic therapy with carbapenems and the antiparasitic ivermectin. Patients with underlying risk factors are at high risk for aggravated infection. Severe strongyloidiasis has a high mortality rate, so early diagnosis is essential to improve prognosis.
Downloads
References
UpToDate[Internet]. EEUU: Edward T Ryan, MD, DTMH; 2015 [09 de septiembre de 2020; 30 de septiembre de 2020]. Disponible en: https://www.uptodate.com/contents/strongyloidiasis?search=strongyloides&source=search_result&selectedTitle=1~83&usage_type=default&display_rank=1Hallal
Buonfrate D, Mena MA, Angheben A, Requena-Mendez A, Muñoz J, Gobbi F, et al.Prevalence of strongyloidiasis in Latin America: a systematic review of the literatura. Epidemiol Infect [Internet]. 2015 [citado 13 May 2020]; 143, 452-460. Disponible en https://doi.org/10.1017/S0950268814001563
Viney ME, Lok JB. The biology of Strongyloides spp. In: WormBook: The Online Review of C. elegans Biology [Internet]. Pasadena (CA): WormBook; 2005-2018. [actualizado 16 jul 2015; citado 13 May 2020] Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK19795/
Barroso M, Salvador F, Sánchez-Montalvá A, Bosch-Nicolau P, Molina I. Strongyloides stercoralis infection: A systematic review of endemic cases in Spain. PLoS Negl Trop Dis. [Internet] 2019. [citado 13 May 2020]; 13(3) 1-14. Disponible en: https://doi.org/10.1371/journal.pntd.0007230
Méndez AR, Buonfrate D. Evidence-Based Guidelines for Screening and Management of Strongyloidiasis in Non-Endemic Countries. Trop. Med [Internet]. 2017 [citado 13 May 2020]; 97(3): 645-652. Disponible en: https://doi.org/10.4269/ajtmh.16-0923
Álava J. Infección pulmonar por Strongyloides stercoralis en la Provincia de Manabí, Ecuador. Revista científica INSPILIP. [Internet]. 2017 [citado 13 May 2020]; 3(1): 1-9. Disponible en: https://bit.ly/2WRw5yV
Farthing M, Albonico M. Manejo de la estrongiloidiasis [Internet]. Organización Mundial de Gastroenterología 2018 [13 May 2020]; Disponible en: https://bit.ly/3g1sy8F
Vasquez RG. Strongyloides stercoralis hyperinfection syndrome: a deeper. J Parasit Dis [Internet]. 2019 [citado 13 May 2020]; 43(2): 167 - 175. Disponible en: https://doi.org/10.1007/s12639-019-01090-x
Posadaa AF. Neumonía severa por Strongyloides stercoralis. Asociación Colombiana de Medicina Crítica y Cuidado lntensivo [Internet] 2015 [citado 13 May 2020]; 15(2): 133-137 Disponible en: https://doi.org/10.1016/j.acci.2015.02.007
Hernández A. Parasitosis con manifestaciones clínicas respiratorias. Medicine Medicine: Programa de Formación Médica Continuada Acreditado [Internet]. 2018 [citado 13 May 2020]; 12(58):395-402. Disponible en: https://doi.org/10.1016/j.med.2018.06.001
Forrer A, Schar F. Strongyloides stercoralis is associated with significant morbidity in rural Cambodia, including stunting in children. PLoS Negl Trop Dis [Internet]. 2017 [citado 13 May 2020]; 11(10): 1-17. Disponible en: https://doi.org/10.1371/journal.pntd.0005685
San Miguel de Vera MC, GiménezOrtigoza VD, Torres Cantero PR, Peralta Galeano AD, Escobar Báez C. Parasitosis intestinal en pacientes tratados con corticoides. Rev. virtual Soc. Parag. Med. Int. [Internet]. 2015. [citado 14 de mayo 2020]; 2 (1): 102-106. Disponible en: http://dx.doi.org/10.18004/rvspmi/2312-3893/2015.02(01)102-106
Hennessey, Ballesteros, Merchán, Guevara, Severiche, Ivermectina subcutánea en el tratamiento de un síndrome de hiperinfección por Strongyloides stercoralis, Biomédica [Internet]. 2020 [citado 30 de septiembre de 2020]; 40(2): 228-32: Disponible en: https://revistabiomedica.org/index.php/biomedica/article/view/5140/4458
